DOI: http://dx.doi.org/10.18203/2349-3933.ijam20162511

Prevalence and associated factors of steroid induced impaired glucose metabolism in obstructive lung diseases, Jimma, and Southwest Ethiopia, Africa

Jarso Tadesse, Prabhanjan Kumar Vata, Reta Kassa Abebe

Abstract


Background: Impaired glucose metabolism is one of the complications of steroid therapy in patients with Obstructive lung diseases. Steroid induced impaired glucose metabolism is a serious, but often overlooked, metabolic disorder; it is largely remains under diagnosed. Although this has been reported from western countries, there is no study that evaluated the prevalence of impaired glucose metabolism and its associated factors in Ethiopia in general and in the study area in particular. Aim of the study was to determine the prevalence and associated factors of steroid induced impaired glucose metabolism in Obstructive lung diseases at Jimma University Specialized Hospital chest clinic from November 2014 to July 2015.

Methods: A hospital based cross-sectional study design was conducted. In this specific study Convenience sampling used. Data was collected through patient interview and chart review. Serum random glucose was determined during Hospital visit. Descriptive statistics and bivariatelogistic regression analysis were done. A P-vale of <0.05 was considered statistically significant.

Results: The study comprised of 90 patients with Asthma and COPD taking systemic steroids visited chest clinic during the study period were included in the analysis. 11.1% of the study subjects had impaired glucose metabolism. The level of RBS level was not associated with any of the independent variables studied (Age and sex of the patient, waist circumference, family history of DM and dose and duration of systemic steroid).

Conclusions: This study found that the prevalence of impaired glucose metabolism in obstructive lung diseases on systemic steroids is significant independent of the effect of dose and duration of steroids.


Keywords


Impaired glucose metabolism, Obstructive lung diseases, Steroid’s (prednisolone), Ethiopia

Full Text:

PDF

References


Longo D, Kasper D, Fauci A. Harrison’s principles of internal medicine. 18th edition, 2012;1549-52.

Endocrine practice. Health services, Medical sciences and Endocrinology. Prevalence and predictors of corticoid-related hyperglycemia in Hospitalized patients. Available at: www.AACE.com, accessed online August 10, 2006.

Papangetal R. A study of steroid-induced diabetes mellitus in leprosy. Indian J Lepr. 2009;81:125-9.

McConnellnetal EM. Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy. Clinical endocrinology. 2001;54(5):593-9.

Price D, Yawn B, Brusselle G, Rossi A. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Prim Care Respir J 2013;22(1):92-100.

Faul JL, Wilson SR, Kuschner WG, The Effect of an Inhaled Corticosteroid on Glucose Control in Type 2 Diabetes. Clin Med Res. 2009;7(1-2):14-20.

O'Byrne PM, Rennard S, Gerstein H, Radner F, Peterson S, Lindberg B, et al. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids Respiratory Medicine. 2012;106(11):1487-93.

Davenport MS, Cohan RH, Khalatbari S, Myles J, Caoili EM, Ellis JH. Hyperglycemia in Hospitalized Patients Receiving Corticosteroid Premedication before the Administration of Radiologic Contrast Medium.Academic Radiology. 2011;18(3):384-90.

Iwamoto T, Kagawa Y, Naito Y, Kojima M. Steroid-Induced Diabetes Mellitus and Related Risk Factors in Patients with Neurologic Diseases. Presented in part at a meeting of the 19th Congress of the Federation of Asian Pharmaceutical Associations, Seoul, Korea, October 7, 2002. Pharmacotherapy. 2004;24(4):508-14.

Derweesh IH, DiBlasio CJ, Kincade MC, Malcolm JB, Lamar KB, Patterson AL, et al. Wake. Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer. BJU international. 2007;100(5):1060-5.

Fardet L, Flahault A, Kettaneh A, Tiev KP, Genereau T, Toledano C, et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. British Journal of Dermatology. 2007;157:142-8.

Caughey GE, Preiss AK, Vitry AI, Gilbert AL, Roughead EE. Impact of corticosteroid use on diabetes complications. Diabetes care. 2013;36(10):3009-14.

Lansang MC, Hustak LK. Glucocorticoid-induced diabetes and adrenal suppression: How to detect and manage them. Cleve Clin J Med. 2011;78(11):748-56.

Kotila TR, Olutogun T, Ipadeola A. Steroid induced diabetes mellitus in patients receiving prednisolone for haematological disorders. Afr Health Sci. 2013;13(3):842-4.

Alonso JLI, Glez-Moro JMR. The Excessive Use Of Inhaled Corticosteroids In Chronic Obstructive Pulmonary Disease. Arch Bronconeumol. 2012;48:207-12.

Kim SY, Yoo C, Yim J. Incidence and Risk Factors of Steroid-induced Diabetes in Patients with Respiratory Disease. J Korean Med Sci. 2011;26(2):264-7.

Mogre V, Salifu ZS, Abedandi R. Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus. Mogre et al. Journal of Diabetes & Metabolic Disorders. 2014,13:8.

Ojewale LY, Adejumo PO. Type 2 Diabetes Mellitus and Impaired Fasting Blood Glucose in Urban South Western Nigeria Department of Nursing, University of Ibadan, Ibadan, Nigeria. Int J Diabetes & Metab. 2012;21:1-9-12

Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S. Type 2 diabetes in adult Nigerians: a study of its prevalenceand risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract. 2003;62(3):177-85.

Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma & Clinical Immunology. 2013,9:3. DOI: 10.1186/1710-1492-9-30.

Gonzalez-Gonzalez JG, Mireles-Zavala LG, Rodriguez-Gutierrez R, Gomez-Almaguer D, Lavalle-Gonzalez FJ, Tamez-Perez HE, et al. Hyperglycemia related to high-dose glucocorticoid use in non-critically ill patients. Gonzalez-Gonzalez et al. Diabetology& Metabolic Syndrome 2013,5:1. doi: 10.1186/1758-5996-5-18

Ito S, Ogishima H, Kondo Y, Sugihara M, Hayashi T, Chino Y, et al. Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases. Mod Rheumatol. 2014;24(1):52-9.

Smyllie HC, Connolly CK. Incidence of serious complications of corticosteroid therapy In respiratory disease. Thorax. 1968;23(6):571-81.

Reda AA, Kotz D, Biadgilign S. Adult tobacco use practice and its correlates in eastern Ethiopia: A cross-sectional study. Harm Reduction Journal. 2013;10:28. DOI: 10.1186/1477-7517-10-28.

Baur X, Bakehe P, Vellguth H. Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach. Journal of Occupational Medicine and Toxicology. 2012,7:19. DOI: 10.1186/1745-6673-7-19.

Sonomjamts M, Dashdemberel S, Logii N, Nakae K, Chigusa Y, Ohhira S, et al. Prevalence of asthma and allergic rhinitis among adult population in Ulaanbaatar, Mongolia. Asia Pac Allergy. 2014;4(1):25-31.

Zemedkun K, Woldemichael K, Tefera G. Assessing Control of Asthma in Jush, Jimma, South West Ethiopia. Ethiop J Health Sci. 2014;24(1):49-58.

Cui L, Gallagher LG, Ray RM, Li W, Gao D, Zhang Y, Vedal S, et al. Unexpected excessive chronic obstructive pulmonary disease mortality among female silk textile workers in Shanghai, China. Occup Environ Med. 2011;68(12):883-7.

Mberikunashe J, Banda S, Chadambuka A, Gombe NT, Shambira G, Tshimanga M, et al. Prevalence and risk factors for obstructive respiratory conditions among textile industry workers in Zimbabwe, 2006. Pan African Medical Journal. 2010; 6:1.

Teklu B. Bronchial Asthma at high altitude: a clinical and laboratory Study in Addis Ababa.Thorax 1989;44:586-7.

Faniran AO, Peat JK, Woolcock AJ. Prevalence of atopy, asthma symptoms and diagnosis, and the management of asthma: comparison of an affluent and a non-affluent country. Thorax. 1999;54:606-10.

Office JUER. Jimma University Specialized Hospital and Existing medical services. 2012 Available from: http://www.ju.edu.et/ jimma-university-specialized-hospital-jush.

Bos M, Agyemang C. Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review. BMC. Public Health. 2013,13:387.

Nshisso LD, Reese A, Gelaye B, Lemma S, Berhane Y, Williams MA. Prevalence of Hypertension and Diabetes among Ethiopian Adults. Diabetes Metab Syndr. 2012;6(1):36-41.

Hilawe EH, Yatsuya H, Kawaguchi L, Aoyama A. Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub Saharan Africa: a systematic review and meta-analysis. Bull World Health Organ. 2013;91(9):671-82D.

Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and management. Diabetes Metab Res Rev. 2014;30(2):96-102.

Jimma Universityspecialized hospital chest referral clinic log book. Available at: https://www.ju.edu.et/ jimma-university-specialized-hospital-jush.